These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3685436)

  • 1. [Plasma lipoproteins and coronary arteriosclerosis].
    Sznajderman M
    Przegl Lek; 1987; 44(6):508-9. PubMed ID: 3685436
    [No Abstract]   [Full Text] [Related]  

  • 2. [Endogenous hypertriglyceridemia].
    Oikawa S
    Nihon Naika Gakkai Zasshi; 1992 Nov; 81(11):1767-71. PubMed ID: 1479216
    [No Abstract]   [Full Text] [Related]  

  • 3. In vivo platelet activity and lipoprotein patterns in coronary artery disease.
    Goubran F; Maklady F; Saad M; el-Ashry M
    Wien Klin Wochenschr; 1986 Apr; 98(7):209-11. PubMed ID: 3705598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum lipoprotein patterns in ischemic heart disease.
    Cupta RC; Sharma SK; Gupta NC
    Indian Heart J; 1980; 32(5):296-302. PubMed ID: 7239548
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-insulin-dependent diabetes mellitus and atherosclerosis: a lipoprotein perspective.
    Hamsten A; Steiner G
    J Intern Med Suppl; 1994; 736():1-3. PubMed ID: 7986301
    [No Abstract]   [Full Text] [Related]  

  • 6. Thrombogenic and atherogenic lipid modifications in plasma and patients with coronary artery disease and after coronary artery bypass surgery.
    Kovacs IB; Jahangiri M; Ridler CD; Görög P; Rees GM
    Rinsho Byori; 1998 Jul; 46(7):656-62. PubMed ID: 9758553
    [No Abstract]   [Full Text] [Related]  

  • 7. [The importance of apolipoproteins in dyslipidemias].
    Quintão EC
    Arq Bras Cardiol; 1988 Feb; 50(2):129-34. PubMed ID: 3063237
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma lipids and coronary atherosclerosis in Japanese men.
    Nakaya Y; Hiasa Y; Morimoto S
    Tokushima J Exp Med; 1993 Dec; 40(3-4):177-82. PubMed ID: 8184414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks.
    Otto C; Ritter MM; Richter WO; Minkenberg R; Schwandt P
    Metabolism; 2001 Feb; 50(2):166-70. PubMed ID: 11229424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can modification of risk factors reduce coronary heart disease?
    Grundy SM
    Cardiovasc Clin; 1983; 13(1):283-96. PubMed ID: 6336670
    [No Abstract]   [Full Text] [Related]  

  • 11. Laboratory-based assessment of plasma lipids and lipoproteins for the classification of familial hypercholesterolemic and hypertriglyceridemic states.
    Demacker PN
    Semin Vasc Med; 2004 Feb; 4(1):13-22. PubMed ID: 15199429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Modified lipoproteins--their types and role in atherogenesis].
    Bratus' VV; Talaieva TV; Lomakovs'kyĭ OM; Tretiak IV; Radalovs'ka NV
    Fiziol Zh (1994); 2000; 46(2):73-81. PubMed ID: 10867865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hyperlipoproteinemia, HDL-cholesterol and arteriosclerosis indices].
    Herrmann W; Reuter W
    Z Gesamte Inn Med; 1982 Dec; 37(24):830-3. PubMed ID: 6963524
    [No Abstract]   [Full Text] [Related]  

  • 14. [Lipoprotein indexes in coronary atheromatosis].
    Pintó Sala J; Fiol Castaño C; Bros Caimari R; Marcos Vidal C
    Rev Clin Esp; 1987 Jan; 180(1):59-60. PubMed ID: 3562976
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of the coronary risk: is it enough to asses ApoB/ApoA1 ratio only or is plasma lipoprotein concentration still necessary?].
    Cybulska B
    Kardiol Pol; 2005 Feb; 62(2):153-6. PubMed ID: 15815801
    [No Abstract]   [Full Text] [Related]  

  • 16. [Blood plasma prostaglandins and their role in disorders of lipid metabolism in ischemic heart disease caused by coronary arteriosclerosis].
    Bochkareva EV; Zykova VP; Lobova NM; Polesskiĭ VA; Gadzhanova SI
    Ter Arkh; 1980; 52(5):18-22. PubMed ID: 7404361
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease.
    Zambon A; Brown BG; Deeb SS; Brunzell JD
    J Intern Med; 2006 May; 259(5):473-80. PubMed ID: 16629853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Low concentrations of high-density lipoproteins (HDL) in plasma and coronary artery disease].
    Pérez-Méndez O; Luc G; Posadas-Romero C
    Arch Inst Cardiol Mex; 2000; 70(3):312-21. PubMed ID: 10959461
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prebeta 1/Lp(a) lipoprotein fraction and its relation to the development of coronary disease].
    Stolarska I
    Kardiol Pol; 1983; 26(1):79-83. PubMed ID: 6348364
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of diet on serum lipoproteins in children with various forms of hyperlipidemias.
    Widhalm K
    Prog Clin Biol Res; 1985; 188():145-59. PubMed ID: 3903768
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.